The effectiveness of anticoagulant and antiplatelet agents in preventing venous thromboembolism during stroke rehabilitation: A historical cohort study

Archives of Physical Medicine and Rehabilitation

Volumn 85, Issue 7, 2004, Pages 1070-1075

  Harvey, Richard L ^a,b   Lovell, Linda L ^a   Belanger, Nicole ^c   Roth, Elliot J ^a,b  

^a REHABILITATION INSTITUTE OF CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c FLETCHER ALLEN HEALTH CARE   (United States)

Author keywords

Anticoagulants; Cerebrovascular accident; Pulmonary embolism; Rehabilitation; Venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN; WARFARIN;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CONFIDENCE INTERVAL; DEEP VEIN THROMBOSIS; GASTROINTESTINAL HEMORRHAGE; HIGH RISK PATIENT; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; LUNG ANGIOGRAPHY; LUNG EMBOLISM; LUNG VENTILATION PERFUSION RATIO; MAJOR CLINICAL STUDY; PHLEBOGRAPHY; PROPHYLAXIS; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STROKE; ULTRASOUND; VENOUS THROMBOEMBOLISM;

AGED; ANTICOAGULANTS; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; COMORBIDITY; FEMALE; HEPARIN; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; PULMONARY EMBOLISM; VENOUS THROMBOSIS;

EID: 3242693554     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apmr.2003.09.012     Document Type: Article

References (41)

1. McCarthy S.T., Turner J. Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke. Age Aging. 15:1986;84-88
2. McCarthy S.T., Turner J.J., Robertson D., Hawkey C.J. Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke. Lancet. 11:1977;800-801
3. Gelmers H.J. Effects of low-dose subcutaneous heparin on the occurrence of deep vein thrombosis in patients with ischemic stroke. Acta Neurol Scand. 61:1980;313-318
4. Turpie A.G., Hirsh J., Jay R.M., et al. Double-blind randomised trial of ORG 10172 low-molecular weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke. Lancet. 1:1987;523-526
5. Prins M.H., Gelsema R., Sing A.K., van Heerde L.R., den Ottolander G.J. Prophylaxis of deep venous thrombosis with a low-molecular-weight heparin (Kabi 2165/Fragmin) in stroke patients. Haemostasis. 19:1989;245-250
6. Elias A., Milandre L., Lagrange G., et al. [Prevention of deep venous thrombosis of the leg by a very low molecular weight heparin fraction (CY 222) in patients with hemiplegia following cerebral infarction a randomized pilot study (30 patients)] [French]. Rev Med Interne. 11:1990;95-98
7. Sandset P.M., Dahl T., Stiris M., Rostad B., Scheel B., Abildgaard U. A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke. Semin Thromb Hemost. 16:(Suppl):1990;25-33
8. Bounds J.V., Wiebers D.O., Whisnant J.P., Okazaki H. Mechanisms and timing of deaths from cerebral infarction. Stroke. 12:1981;474-477
9. Brown M., Glassenberg M. Mortality factors in patients with acute stroke. JAMA. 224:1973;1493-1495
10. Viitanen M., Winblad B., Asplund K. Autopsy verified causes of death after stroke. Acta Medica Scand. 222:1987;401-408
11. Wijdicks E., Scott J. Pulmonary embolism associated with acute stoke. Mayo Clin Proc. 72:1997;297-300
12. Cope C., Reyes T.M., Skversky N.J. Phlebographic analysis of the incidence of thrombosis in hemiplegia. Radiology. 109:1973;581-584
13. Miyamoto A.T., Miller L.S. Pulmonary embolism in stroke prevention by early heparinization of venous thrombosis detected by iodine-125 fibrinogen leg scans. Arch Phys Med Rehabil. 61:1980;584-587
14. Sioson E.R., Crowe W.E., Dawson N.V. Occult proximal deep vein thrombosis its prevalence among patients admitted to a rehabilitation hospital. Arch Phys Med Rehabil. 69:1988;183-185
15. Pambianco G., Orchard T., Landau P. Deep vein thrombosis prevention in stroke patients during rehabilitation. Arch Phys Med Rehabil. 76:1995;324-330
16. Oczkowski W.J., Ginsberg J.S., Shin A., Panju A. Venous thromboembolism in patients undergoing rehabilitation for stroke. Arch Phys Med Rehabil. 73:1992;712-716
17. Harvey R.L., Roth E.J., Yarnold P.R., Durham J.R., Green D. Deep vein thrombosis in stroke the use of plasma D-dimer level as a screening test in the rehabilitation setting. Stroke. 27:1996;1516-1520
18. Dahan R., Houlbert D., Caulin C., et al. Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin a randomized double-blind trial. Haemostasis. 16:1986;159-164
19. Green D., Akuthota V., Eiken M., et al. Prevention of thromboembolism in stroke rehabilitation patients. Top Stroke Rehabil. 5:1998;68-74
20. Turpie A.G., Gent M., Cote R., et al. A low-molecular weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke a randomized, double-blind study. Ann Intern Med. 117:1992;353-377
21. Dumas R., Woitinas F., Kutnowski M., et al. A multicentre, double-blind, randomized study to compare the safety and efficacy of once-daily ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis in patients with acute ischaemic stroke. Age Aging. 23:1994;512-516
22. Hillbom M., Erila T., Sotaniemi K., Tatlisumak T., Sarna S., Kaste M. Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke a randomized, double-blind study. Acta Neurol Scand. 106:2002;84-92
23. Geerts W.H., Heit J.A., Clagett G.P., et al. Prevention of venous thromboembolism. Chest. 119:(Suppl 1):2001;132S-175S
24. Goldstein L.B., Bertels C., David J.N. Inter-rater reliability of the NIH stroke scale. Arch Neurol. 46:1989;660-662
25. Heinemann A.W., Harvey R.L., McGuire J.R., et al. Measurement properties of the NIH stroke scale during acute rehabilitation. Stroke. 28:1997;1174-1180
26. Dalen J.E. Pulmonary embolism what have we learned since Virchow? Natural history, pathophysiology, and diagnosis. Chest. 122:2002;1440-1456
27. Samama M.M., Desnoyers P.C., Conard J., Bousser M.G. Acute ischemic stroke and heparin treatments. Thromb Haemost. 78:1997;173-179
28. Koenig W. Haemostatic risk factors for cerebrovascular diseases. Eur Heart J. 19:(Suppl C):1998;C39-C43
29. Rosenberg R.D., Bauer K.A. Does a prethrombotic state exist? If so, what is it? Am J Clin Nutr. 56:(Suppl 4):1992;787S-788S
30. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation Stroke Prevention in Atrial Fibrillation II Study. Lancet. 343:1994;687-691
31. International Stroke Trial Collaborative Group. The international stroke trial (IST) a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet. 349:1997;1569-1581
32. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet. 349:1997;1641-1649
33. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ. 308:1994;81-8106. [published erratum in: BMJ 1994;308:1540]
34. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 348:1996;1329-1339
35. Diener H.C., Cunha L., Forbes C., Sivenius J., Smets P., Lowenthal A. European stroke prevention study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 143:1996;1-13
36. Gubitz G., Sandercock P., Counsell C. Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev. (4):2002;CD000029
37. Kitamura T., Ito K. Acute gastric changes in patients with acute stroke. Part 1: with reference to gastroscopic findings. Stroke. 7:1976;460-463
38. Davenport R.J., Dennis M.S., Warlow C.P. Gastrointestinal hemorrhage after acute stroke. Stroke. 27:1996;421-424
39. Roth E.J., Lovell L., Harvey R.L., Heinemann A.W., Semik P., Diaz S. Incidence of and risk factors for medical complications during stroke rehabilitation. Stroke. 32:2001;523-529
40. Degen J.L. Hemostatic factors and inflammatory disease. Thromb Haemost. 82:1999;858-864
41. Roth E.J., Lovell L., Harvey R.L., Bode R.K., Heinemann A.W. Stroke rehabilitation indwelling urinary catheters, enteral feeding tubes, and tracheostomies are associated with resource use and functional outcomes. Stroke. 33:2002;1845-1850